QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software

References

• CT Supuran. (2008). Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Rev Drug Disc 7:168–181.
   PubMed Web of Science ®Google Scholar
• F Mincione, L Menabuoni, and CT Supuran. Clinical applications of the Carbonic anhydrase inhibitors in ophthalmology. In: C Supuran, A Scozzafava, and J Conway, editors. Carbonic anhydrase, its inhibitors and activators. Boca Raton (FL): CRC Press; (2004). p 243–254.
   Google Scholar
• CT Supuran, A Scozzafava, and J Conway, editors. Carbonic anhydrase–its inhibitors and activators. Boca Raton (USA): CRC Press; (2004). p 1–363.
   Google Scholar
• BW Clare, and CT Supuran. QSAR studies of sulfonamide carbonic anhydrase inhibitors. In: CT Supuran, A Scozzatava, and J Conway, editors. Carbonic andydrase, its inhibitors and activators. Boca Raton, FI, USA: CRC Press; (2004).
   Google Scholar
• CT Supuran. Carbonic anhydrases: Catalytic and inhibition mechanisms, distribution and physiological roles. In: I Pacscas, editor. Carbonic anhydrase and modulation of physiologic and pathologic process in the organism. Timisoara (Romania): Helicon; (1994). p 29–111.
   Google Scholar
• CT Supuran, A Scozzafava, and A Casini. Development of sulfonamide carbonic anhydrase inhibitors (CAIs). In: CT Supuran, A Scozzafava, and J Conway. Carbonic anhydrase, its inhibitors and activators. Boca Raton (FL): CRC Press; (2004). p 67–148.
   Google Scholar
• CT Supuran, A Scozzafava, and A Casini. (2003). Carbonic anhydrase inhibitors. Med Res Rev 23:146–189.
   PubMed Web of Science ®Google Scholar
• K Fujikawa-adachi, I Nishimori, T Taguchi, and S Onishi. (1999). J Biol Chem 274:21228.
   PubMed Web of Science ®Google Scholar
• S Asida, I Nishimori, M Tanimura, S Onishi, and T Shuri. (2002). J Cancer Res Clin Oncol 128:561.
   PubMedGoogle Scholar
• BW Clare, and CT Supuran. (2006). A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol 2:113.
   PubMed Web of Science ®Google Scholar
• J Singh, S Singh, PV Khadikar, CT Supuran, BW Clare, and M Lakhwani. (2008). Estimation of human carbonic anhydrase II inhibition using topological indices and their combination with quantum- theoretical descriptors. Med Chem 4:30–66.
   PubMedGoogle Scholar
• CT Supuran, A Scozzafava, and J Conway, editors. Carbonic anhydrase–its inhibitors and activators. Boca Raton (USA): CRC Press; (2004). p 1–363.
   Google Scholar
• VK Agrawal, J Singh, A Pandey, and PV Khadikar. (2006). Modeling of inhibitory activities of sulfonamide schiff bases using physicochemical parameters. Oxid Commun 29:803–816.
   Google Scholar
• L Tarko. (2007). QSAR studies regarding the inihibition of the carbonic anhydrase by the sulfonamides containing a picolinyl group. Rev Chim (Bucuresti) 58:191–194.
   Web of Science ®Google Scholar
• PV Khadikar, BW Clare, AT Balaban, CT Supuran, VK Agrawal, J Singh, AK Joshi, and M Lakhwani. (2006). QSAR predection of CAI, CAII, CAIV inhibitory activities: Relative potential of balaban and balaban type indices. Rev Roum Chem 51:703–717.
   Google Scholar
• M Jaiswal, PV Khadikar, A Scozzafava, and CT Supuran. (2004). Carbonic anhydrase inhibitors: The first QSAR study on inhibition of tumour associated isoenzyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 14:3283–3290.
   PubMed Web of Science ®Google Scholar
• PV Khadikar, MV Diudea, J Singh, A Shrivastva, S Singh, S Karmarkar, M Lakhwani, and P Thakur. (2006). Use of PI index in computer-aided designing of bioactive compounds. Curr Bioact Comp 2:19–56.
   Google Scholar
• VK Agrawal, S Bano, CT Supuran, and PV Khadikar. (2004). QSAR study on carbonic anhydrase inhibitors: Aromatic/heterocyclic sulfonamides containing 8-quinoline moieties with topical activity as anti-glauoma agents. Eur J Med Chem 39:593–600.
   PubMed Web of Science ®Google Scholar
• PV Khadikar, V Sharma, S Karmarkar, and CT Supuran. (2005). QSAR studies on benzene sulfonamide carbonic anhydrase inhibitors: Need of hydrophobic parameter for topological modeling of binding constants of sulfonamides to human CA-II. Bioorg Med Chem Lett 15:923–930.
   PubMed Web of Science ®Google Scholar
• PV Khadikar, BW Clare, AT Balaban, CT Supuran, VK Agrawal, J Singh, AK Joshi, and M Lakhwani. (2006). QSAR predection of CAI,CAII, CAIV inhibitory activities: Relative potential of balaban and balaban type indices. Rev Roum Chem 51:703–717.
   Google Scholar
• PV Khadikar, YA Jaliwala, M Lakhwani, P Thakur, S Joshi, and AK Joshi. (2006). QSAR studies on inhibitoty properties of benzinesulphonamides towards CA-I: Domaminating role of van der Waals repulsion energy. Bioinformatics Trends 1:125–136.
   Google Scholar
• PV Khadikar, BW Clare, AT Balaban, CT Supuran, VK Agrawal, J Singh, AK Joshi, and M Lakhwani. (2006). Estimation of human carbonic anhydrase II inhibition using topological indices and their combination with quantum- theoretical descriptors. J Med Chem Res 15:156–160.
   Google Scholar
• VK Agrawal, J Singh, A Pandey, and PV Khadikar. (2006). Modeling of inhibitory activities of sulfonamide schiff bases using physicochemical parameters. Oxid Commun 29:803–816.
   Google Scholar
• PV Khadikar, O Deeb, A Jaber, J Singh, and M Lakhwani. (2006). Development of quantitative structure- activity relationship for a set of carbonic anhydrase inihibitors: Use of quantum and chemical descriptors. Lett Drug Design Discov 3:622–635.
   Google Scholar
• AT Balaban, PV Khadikar, CT Supuran, A Thakur, and M Thakur. (2005). Study on supramolecular complexing ability vis-à-vis estimation of pKa of substituted sulfonamides: Dominating role of balaban index (J). Bioorg Med Chem Lett 15:3966–3973.
   PubMed Web of Science ®Google Scholar
• I Nishimori, D Vullo, A Innocenti, A Scozzafava, A Mastrolorenzo, and CT Supuran. (2005). Carbonic anhydrase inihibitors: Inihibition of the transmembrane isozyme XIV with sulfomamides. Bioorg Med Chem Lett 15:3828–3833.
   PubMed Web of Science ®Google Scholar
• L Tarko, I Lupescu, and D Groposila-Constantinescu. (2005). Sweetness power QSARs by PRECLAV software. Arkivoc 10:254–271.
   Google Scholar
• PRECLAV v.0601 program is available from Center of Organic Chemistry (CCO) Bucharest, Romanian Academy; Director CCO E-mail address: [email protected].
   Google Scholar
• HyperChem7.52 Software, Hypercube Inc. Florida Science and Technology Park,1115 N.W. 4th street Gainesvilla Florida, 326001, USA; 2006. http://www.hyper.com/.
   Google Scholar
• ADDREIT T., STANCU S., Statistica, Ed. ALL, Bucuresti, 1995, p 341.
   Google Scholar
• Sybyl 7.2 Tripos Inc., 1699 Hanley Road, St.Louis MO 63144see www.tripos.com.
   Google Scholar
• JG Vinter, A Davis, and MR Saunders. (1987). J Comp-Aided Design Mol 1:31.
   PubMedGoogle Scholar
• Stewart JJP. Mopac93, Fujitsu Ltd., Tokyo, Japa.
   Google Scholar
• S Charterjee, AS Hadi, and B Price. Regression analysis by examples. 3rd ed.New York: Wiley; (2000).
   Google Scholar
• NCSS(statistical Software Delux package), 329 North 1000 East; Kaysville, UT, USA, 2004.
   Google Scholar